Drugs / KW-2478
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00457782 | Apr 2007 → Aug 2010 | B-cell chronic lymphocytic leukemia, plasma cell myeloma | Kyowa Kirin, Inc. | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01063907 | Mar 2010 → Nov 2013 | plasma cell myeloma | Kyowa Kirin, Inc. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KW-2478 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01063907 ↗ |
| Action | Inhibit | “HSP90 Inhibitor” NCT01063907 ↗ |
| Modality | Small molecule | — CHEMBL4300557 ↗ |
| Route | Intravenous | “intravenous KW-2478” NCT00457782 ↗ |